Development of a recombinant tetravalent dengue vaccine based on a subunit envelo
Ended Project Grant Awarded Last action
- Award ID
- R01AI105206
- Recipient
-
Vaxinnate Corporation UEI K61HKG4JFH99
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,599,766
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- Cranbury, NJ, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$584,226 | |
| Amendment | $0 | |
| Amendment | $754,080 | |
| Amendment | $683,222 | |
| Original award | $746,690 |
Quick answers
Who received award R01AI105206?
R01AI105206 was awarded to Vaxinnate Corporation by National Institutes of Health (Department of Health and Human Services) on April 1, 2013.
How much is award R01AI105206 worth?
$1,599,766 has been obligated on R01AI105206.
Which agency awarded R01AI105206?
National Institutes of Health (Department of Health and Human Services) awarded R01AI105206, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award